Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Sorbic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 6/20 | 0.32 |
| ▸ | CNR1 | P21554 | 4/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sorbic Acid SCHEMBL1759655 | 1.00 | CA4 (0.36) | CA4BBOX1CA1ALDH1A1CNR2 | |
| Sorbic Acid SCHEMBL2353831 | 0.97 | CA4 (0.38) | CA4BBOX1CA1ALDH1A1CNR2 | |
| Sorbic Acid SCHEMBL28680231 | 0.97 | CA4 (0.38) | CA4BBOX1CA1ALDH1A1CNR2 | |
| Sorbic Acid SCHEMBL41692 | 0.97 | — | — | |
| Sorbic Acid SCHEMBL29963629 | 0.97 | CA4 (0.38) | CA4BBOX1CA1ALDH1A1CNR2 | |
| Sorbic Acid SCHEMBL41693 | 0.97 | — | — | |
| Sorbic Acid SCHEMBL146360 | 0.97 | BBOX1 (0.36) | CA4BBOX1CA1ALDH1A1CNR2 | |
| Sorbic Acid SCHEMBL146359 | 0.97 | BBOX1 (0.36) | CA4BBOX1CA1ALDH1A1CNR2 | |
| Sorbic Acid SCHEMBL27789796 | 0.97 | BBOX1 (0.36) | CA4BBOX1CA1ALDH1A1CNR2 | |
| Sorbic Acid SCHEMBL5328357 | 0.95 | CA4 (0.43) | CA4BBOX1CA1ALDH1A1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024128333-A1 | COMPOSITION USING VERATRUM VERSICOLOR EXTRACT FOR REDUCING SKIN WRINKLES AND WHITENING SKIN | 주식회사 뉴셀팜 | 2024-06-20 | — | — | WO | disclosed |
| WO-2023224134-A1 | COMPOSITION FOR IMPROVING COGNITIVE ABILITY USING WATER SOLUBLE CURCUMIN AND BOSWELLIA EXTRACTS | 주식회사 다미래 | 2023-11-23 | — | — | WO | disclosed |
| CN-115667493-A | Novel radioresistant deinococcus strains, exopolysaccharides derived therefrom and compositions containing same | 韩国原子力研究院 | 2023-01-31 | — | — | CN | disclosed |
| CN-114729335-A | Mono-or dihydroxy derivatives of polyunsaturated fatty acids, method for the production thereof and use thereof | 韩国生命工学研究院 | 2022-07-08 | — | — | CN | disclosed |
| US-11191746-B2 | Composition for inhibiting a growth of cancer stem cells comprising ciclesonide | JEJU NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2021-12-07 | — | — | US | disclosed |
| CN-111989399-A | Process for preparing polyhydroxy derivatives of polyunsaturated fatty acids | 韩国生命工学研究院 | 2020-11-24 | — | — | CN | disclosed |
| US-20200246307-A1 | COMPOSITION FOR INHIBITING A GROWTH OF CANCER STEM CELLS COMPRISING CICLESONIDE | JEJU NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2020-08-06 | — | — | US | disclosed |
| CN-110366419-A | Composition for inhibiting side effects of cytotoxic anticancer agent using ginsenoside compound K | 恩进生物科技有限公司 | 2019-10-22 | — | — | CN | disclosed |
| CN-103271303-B | Method for preparing raw material for functional foods from barley or wheat seeds | JEJUHONGAMGA | 2014-12-17 | — | — | CN | disclosed |
| CN-102058067-B | Method for preparing raw material for functional food from barley or wheat seeds | LEE GYU-GIL | 2013-10-30 | — | — | CN | disclosed |
| CN-103271303-A | Method for preparing raw material for functional foods from barley or wheat seeds | JEJUHONGAMGA | 2013-09-04 | — | — | CN | disclosed |
| CN-102058067-A | Method for preparing raw material for functional food from barley or wheat seeds | GYU-GIL LEE | 2011-05-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11191746-B2 | Composition for inhibiting a growth of cancer stem cells comprising ciclesonide | STAT3, CD44, MYC | CA4 432/4885BBOX1 3704/4885CA1 740/4885 |
| US-20200246307-A1 | COMPOSITION FOR INHIBITING A GROWTH OF CANCER STEM CELLS COMPRISING CICLESONIDE | STAT3, CD44, MYC | CA4 432/4885BBOX1 3704/4885CA1 740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.